the prognostic value of self-reported fatigue on overall survival in patients with mds
Published 1 year ago • 57 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
1:30
the prognostic value of patient-reported outcomes in mds
-
1:26
current and emerging prognostic factors for mds/mpn
-
2:18
prognostic factors and mutations in mds
-
1:55
mds genomics: diagnosis and prognosis
-
3:23
the prognostic impact of pre-transplant mrd-positivity in patients with aml
-
3:35
real-world validation of the value of the ipss-m for prognostication in patients with mds
-
1:19
the prognostic value of mrd in cll
-
1:25
prognosis and treatment in high-risk mds
-
49:25
myelodysplastic syndrome (mds) and anemia
-
3:53
the benefits of hyperbaric oxygen therapy (hbot)
-
3:54
life with mds: jill shares how her family helped her overcome an mds diagnosis
-
1:16
state of the art: mds
-
2:43
novel therapies in the future of mds treatment
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
-
2:04
state-of-the-art treatment for hr-mds
-
2:16
current and future treatment approaches for hr-mds
-
1:19
the promise of precision medicine in mds
-
1:05
the prognostic and potentially therapeutic value of liquid biopsy in multiple myeloma
-
1:04
the future of mds management
-
1:59
the role of mrd as a prognostic & predictive biomarker in cll
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
18:24
prognostic value of evaluating mrd dynamics in multiple myeloma maintenance